baha the information company

baha is a leading provider of real-time market data, financial news, technology and solutions for the financial industry. baha offers real-time data terminals for professionals, global financial market data covering over 12 million financial instruments on more than 150 exchanges, as well as 24/7 breaking news with global coverage and free web and mobile apps. From a total of around 200 real-time data providers worldwide, only Reuters 1851, Bloomberg 1981 and now baha in 2021 were named after the founder.

ELI LILLY/ US5324571083 /

13/07/2024 13:02:49	Chg. -1.400	Volume	Bid13:02:49	Ask13:02:49	Market Capitalization	Dividend Y.	P/E Ratio
865.100EUR	-0.16%	- Turnover: -	865.100Bid Size: -	872.100Ask Size: -	826.07 bill.EUR	-	-

TeleTrader 08/07 Eli Lilly launches $3.2B tender offer for Morphic

TeleTrader 02/07 US FDA approves Eli Lilly's Alzheimer's drug

GlobeNewswire 01/07 Ovid Therapeutics and Graviton Bioscience Announce Topline Data from a Phase 1 Clinical Trial Studyi...

GlobeNewswire 28/06 Atossa Therapeutics Announces Updated Protocol for Clinical Trial Evaluating (Z)-Endoxifen in Combin...

TeleTrader 25/06 Lilly partners with OpenAI to combat drug-resistance bacteria

GlobeNewswire 21/06 HUTCHMED Announces European Commission Approval for FRUZAQLA® (fruquintinib) Received by Takeda

GlobeNewswire 19/06 Jasper Therapeutics Announces Appointment of Svetlana Lucas Ph.D., to its Board of Directors

GlobeNewswire 17/06 CytomX Therapeutics Promotes Chris Ogden to Chief Financial Officer

GlobeNewswire 17/06 Atossa Set to Join Russell 3000® Index Effective June 28, 2024

GlobeNewswire 14/06 TScan Therapeutics Announces Updates to its Board of Directors

GlobeNewswire 12/06 US Gastroenterologists Express Anticipation for Approval of AbbVie’s Skyrizi in Ulcerative Colitis, ...

GlobeNewswire 11/06 Global Multiple Sclerosis Drugs Market Size Projected to Reach $38 Billion By 2032 as Demand on R&D ...

GlobeNewswire 11/06 Skyhawk Therapeutics Promotes Clint Musil to Chief Executive Officer and Appoints Co-founder Bill Ha...

GlobeNewswire 11/06 Adverum Biotechnologies Announces Appointments of Dr. Rabia Gurses Ozden as Chief Medical Officer an...

GlobeNewswire 11/06 Biora Therapeutics Announces Presentation on the BioJet™ Systemic Oral Delivery Platform at the Next...

TeleTrader 10/06 FDA advisors endorse Eli Lilly's Alzheimer's drug

Newsfile Corp 10/06 Guest Invitation to Momentum AI Summit in July

GlobeNewswire 10/06 Sermonix Pharmaceuticals Announces Breast Cancer Research Publication of Paper Examining Lasofoxifen...

GlobeNewswire 10/06 RenovoRx Appoints Ryan Witt as Senior Vice President, Head of Corporate Strategy and Partnerships

GlobeNewswire 06/06 Sermonix Pharmaceuticals Announces Chinese Approval of Investigational New Drug Application for Laso...

GlobeNewswire 06/06 Vaccinex Reports Completion of Last Patient Visit in Randomized, SIGNAL-AD Phase 1b/2 Study of Pepin...

TeleTrader 05/06 Alphabet appoints Anat Ashkenazi as new CFO

GlobeNewswire 04/06 CytoSorbents STAR Registry Data on Patients on Ticagrelor Undergoing CABG Surgery with CytoSorb Pres...

GlobeNewswire 03/06 BIOPHTA raises 6.5 million Euros Seed Funding to transition its New Standard of Care for Eye Disease...

GlobeNewswire 03/06 HUTCHMED Highlights Publication of Phase III FRUTIGA Results in Nature Medicine

ELI LILLY/ US5324571083 /

If you wish to receive reply to your feedback, please provide your email address.